A cell-based drug delivery platform for treating central nervous system inflammation.
Levy O, Rothhammer V, Mascanfroni I, Tong Z, Kuai R, De Biasio M, Wang Q, Majid T, Perrault C, Yeste A, Kenison JE, Safaee H, Musabeyezu J, Heinelt M, Milton Y, Kuang H, Lan H, Siders W, Multon MC, Rothblatt J, Massadeh S, Alaamery M, Alhasan AH, Quintana FJ, Karp JM.
Levy O, et al. Among authors: quintana fj.
J Mol Med (Berl). 2021 May;99(5):663-671. doi: 10.1007/s00109-020-02003-9. Epub 2021 Jan 4.
J Mol Med (Berl). 2021.
PMID: 33398468
Free PMC article.